Hypertrophy of the non-embolized liver after chemotherapy

HPB

Volumn 11, Issue 2, 2009, Pages 103-107

  Nafidi, Otmane ^a   Désy, Delphine ^a   Létoumeau, Richard ^a   Côté, Jean ^a   Plasse, Marylène ^a   Vandenbroucke, Franck ^a   Roy, André ^a   Dagenais, Michel ^a   Lapointe, Réal W ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Chemotherapy; Colorectal liver metastases; Hepatectomy; Liver hypertrophy; Portal vein embolization

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FUTURE REMNANT LIVER HYPERTROPHY; HOSPITALIZATION; HUMAN; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER RESECTION; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PLEURA EFFUSION; PORTAL VEIN EMBOLIZATION; STEATOSIS; TREATMENT RESPONSE;

EID: 66949139455     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00004.x     Document Type: Article

References (36)

1. Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S et al. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983-4990.
2. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-724.
3. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037-1051.
4. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D et al. (2004) Rescue surgery for unresectable colorectal liver metastases down-staged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644-658.
5. Lupinacci R, Penna C, Nordlinger B. (2007) Hepatectomy for resectable colorectal cancer metastases indicators of prognosis, definition of resectability, techniques and outcomes. Surg Oncol Clin N Am 16:493-506.
6. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356:1545-1559.
7. Adam R, Lucidi V, Bismuth H. (2004) Hepatic colorectal metastases: methods of improving resectability. Surg Clin N Am 84:659-671.
8. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B et al. (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052-1064.
9. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208-217.
10. Kemeny N. (2007) Presurgical chemotherapy in patients being considered for liver resection. Oncologist 12:825-839.
11. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P et al. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving pre-operative chemotherapy. Ann Surg 247:118-124.
12. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460-466.
13. Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. (2006) Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 10:365-370.
14. Di Stefano DR, de Baere T, Denys A, Hakime A, Gorin G, Gillet M et al. (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625-630.
15. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. (2006) Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 12:117-123.
16. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al. (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480-486.
17. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B et al. (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7.
18. Sahajpal A, Vollmer CM Jr, Dixon E, Chan EK, Wei A, Cattral MS et al. (2007) Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect perioperative outcomes. J Surg Oncol 95:22-27.
19. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274-286.
20. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034-1044.
21. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292-298.
22. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46.
23. Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082-1088.
24. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072.
25. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853.
26. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S et al. (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247:451-455.
27. Beal IK, Anthony S, Papadopoulou A, Hutchins R, Fusai G, Begent R et al. (2006) Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 79:473-478.
28. Yokoyama Y, Nagino M, Nimura Y. (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31:367-374.
29. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. (2008) Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 143:476-482.
30. Black DM, Behrns KE. (2002) A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration. Surg Oncol Clin N Am 11:849-864.
31. Harada H, Imamura H, Miyagawa S, Kawasaki S. (1997) Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology 26:1162-1170.
32. Kohno H, Inokuchi K. (1984) Effects of postoperative adjuvant chemotherapy on liver regeneration in partially hepatectomized rats. Jpn J Surg 14:515-523.
33. Hewes JC, Riddy D, Morris RW, Woodrooffe AJ, Davidson BR, Fuller B. (2006) A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy. J Hepatol 45:263-270.
34. Elias D, Ouellet JF, De Baère T, Lasser P, Roche A. (2002) Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 131:294-299.
35. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M et al. (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-272.
36. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784-788.